Dermazor

Manufacturer: PRESTIGIO LTD
Effective date: 2020-01-16
Label type: HUMAN OTC DRUG LABEL
Version: 5
Source: full-release
Hydrated at: 2026-05-31 23:02:56

Label at a glance#

ProductDermazor Psoriasis and Seborrheic Dermatitis

Active ingredientSALICYLIC ACID

Label structure10 sections

Indications and uses

Relieves and helps prevent symptomatic recurrence of the skin: Itching Irritation Redness Flaking Scaling Dryness

Dosage and administration

Apply to the affected areas two to four times daily or as directed by a medical doctor.

Contacts and useful links#

PhoneLabel contact754.816.5411

Websitewww.dermazor.com

www.DermaZor.com

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 3%

Purpose

OTC - PURPOSE SECTION

Psoriasis and Seborrheic Dermatitis

Uses

INDICATIONS & USAGE SECTION

Relieves and helps prevent symptomatic recurrence of the skin:

Itching
Irritation
Redness
Flaking
Scaling
Dryness

Warnings

WARNINGS SECTION

For external use only.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center immediately.

When using this product

OTC - WHEN USING SECTION

avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

condition worsens or does not improve after regular use as directed.

Side effects

ADVERSE REACTIONS SECTION

DermaZor has no side effects. If you are allergic to any of the ingredients in the cream, do not use.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply to the affected areas two to four times daily or as directed by a medical doctor.

Other Information

SPL UNCLASSIFIED SECTION

Keep carton for full drug facts.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

anthemis nobilis flower oil, beeswax, bisabolol, borago officianalis seed oil, calamine, calendula officinalis flower oil, cannabis sativa seed oil, lanolin, lavandula angustifolia oil, linum usitatissimum seed oil, nigella sativa seed oil, oenothera biennis (evening primrose) oil, petrolatum, phenoxyetahnol,
polysorbate 80, prunus amygdalus dulcis (sweet almond) oil, retinyl palmitate (vitamin A), silybum marinum seed oil, sorbitan tristearate, tocopheryl
acetate (vitamin E), vitis vinifera (grape) seed oil, water, zea mays (corn) starch, zinc oxide.

Questions or Comments:

OTC - QUESTIONS SECTION

support@DermaZor.com

Website: www.DermaZor.com

SPL UNCLASSIFIED SECTION

Distributed by: DISTR.MED.LLC USA
Stirling RD Davie, Florida 33024 | T 754.816.5411

Made in Israel | www.DermaZor.com
FDA OTC Listed | NDC #63302-202-02

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC: 63302-202-02

DermaZor Psoriasis

MEDICATED SKIN TREATMENT

Psoriasis and Seborrheic Dermatitis Cream

Hypoallergenic No Side Effects

Relieves and helps prevent Symptomatic recurrences:

Itching
Irritation
Redness
Flaking
Scaling
Dryness

A Patented Unique Formula

3% Salicylic Acid, Zinc and Cannabis Oil Complex

Non-Steroidal, Non-Coal Tar

FL OZ | 100 ml 3.5

Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1537091	Dermazor 3 % Topical Cream	PSN	5
416910	salicylic acid 3 % Topical Cream	PSN	5
1537091	salicylic acid 30 MG/ML Topical Cream [Dermazor]	SBD	5
416910	salicylic acid 30 MG/ML Topical Cream	SCD	5
1537091	Dermazor 3 % Topical Cream	SY	5
1537091	Dermazor 30 MG/ML Topical Cream	SY	5
416910	salicylic acid 3 % Topical Cream	SY	5

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63302-202-01	2022-01-28	C162847	48780-1	d6a99b39-5168-a426-e053-dadaa90af4c2	Drug Facts
63302-202-02	2022-01-28	C162847	48780-1	d6a99b39-5168-a426-e053-dadaa90af4c2	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63302-202-01	DermazorPsoriasis and Seborrheic Dermatitis	100 g in 1 TUBE	CREAM	100		5
63302-202-02	DermazorPsoriasis and Seborrheic Dermatitis	100 g in 1 TUBE	CREAM	100		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63302-202	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	5	Legacy NDC, 2 package rows	20200117_df95a616-714e-4727-af91-1b993a55b661.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	1
.ALPHA.-TOCOPHEROL	INACTIVE INGREDIENT	H4N855PNZ1	1
ALMOND OIL	INACTIVE INGREDIENT	66YXD4DKO9	1
BORAGE OIL	INACTIVE INGREDIENT	F8XAG1755S	1
CALENDULA OFFICINALIS FLOWER	INACTIVE INGREDIENT	P0M7O4Y7YD	1
CHIA SEED OIL	INACTIVE INGREDIENT	MC2LH51BO7	1
EVENING PRIMROSE OIL	INACTIVE INGREDIENT	3Q9L08K71N	1
GRAPE SEED OIL	INACTIVE INGREDIENT	930MLC8XGG	1
LANOLIN	INACTIVE INGREDIENT	7EV65EAW6H	1
LAVENDER OIL	INACTIVE INGREDIENT	ZBP1YXW0H8	1
LEVOMENOL	INACTIVE INGREDIENT	24WE03BX2T	1
NIGELLA SATIVA SEED OIL	INACTIVE INGREDIENT	CS4U38E731	1
PETROLATUM	INACTIVE INGREDIENT	4T6H12BN9U	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	1
SILYBUM MARIANUM SEED OIL	INACTIVE INGREDIENT	NYY23HEN06	1
VITAMIN A	INACTIVE INGREDIENT	81G40H8B0T	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1
WHITE WAX	INACTIVE INGREDIENT	7G1J5DA97F	1
ZINC OXIDE	INACTIVE INGREDIENT	SOI2LOH54Z	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

Dermazor Psoriasis and Seborrheic Dermatitis
Salicylic Acid, Zinc Oxide
SALICYLIC ACID
LANOLIN
PETROLATUM
WATER
ZINC OXIDE
STARCH, CORN
GRAPE SEED OIL
CANNABIS SATIVA SEED OIL
CALENDULA OFFICINALIS FLOWER
CHAMAEMELUM NOBILE FLOWER OIL
EVENING PRIMROSE OIL
WHITE WAX
POLYSORBATE 65
POLYSORBATE 80
SILYBUM MARIANUM SEED OIL
PHENOXYETHANOL
VITAMIN A
VITAMIN D
BORAGE SEED OIL
ALMOND OIL
LEVOMENOL
NIGELLA SATIVA SEED OIL
LAVENDER OIL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
63302-202	63302-202-01, 63302-202-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SALICYLIC ACID	O414PZ4LPZ	ACTIB
LANOLIN	7EV65EAW6H	IACT
PETROLATUM	4T6H12BN9U	IACT
WATER	059QF0KO0R	IACT
ZINC OXIDE	SOI2LOH54Z	IACT
STARCH, CORN	O8232NY3SJ	IACT
GRAPE SEED OIL	930MLC8XGG	IACT
CANNABIS SATIVA SEED OIL	69VJ1LPN1S	IACT
CALENDULA OFFICINALIS FLOWER	P0M7O4Y7YD	IACT
CHAMAEMELUM NOBILE FLOWER OIL	UB27587839	IACT
EVENING PRIMROSE OIL	3Q9L08K71N	IACT
WHITE WAX	7G1J5DA97F	IACT
POLYSORBATE 65	14BGY2Y3MJ	IACT
POLYSORBATE 80	6OZP39ZG8H	IACT
SILYBUM MARIANUM SEED OIL	NYY23HEN06	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
VITAMIN A	81G40H8B0T	IACT
VITAMIN D	9VU1KI44GP	IACT
BORAGE SEED OIL	F8XAG1755S	IACT
ALMOND OIL	66YXD4DKO9	IACT
LEVOMENOL	24WE03BX2T	IACT
NIGELLA SATIVA SEED OIL	CS4U38E731	IACT
LAVENDER OIL	ZBP1YXW0H8	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 148 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	CAPSULE, EXTENDED RELEASE / ORAL		8 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / ORAL		27120 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / TOPICAL	5.28 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	SOLUTION / RESPIRATORY (INHALATION)	3.11 %w/v		Exact identifier — unii candidate 6 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	CAPSULE, EXTENDED RELEASE / ORAL	0.07 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / OPHTHALMIC	0.6 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	LOTION / TOPICAL	16 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUPPOSITORY / VAGINAL	252 mg		Exact identifier — unii candidate 81 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	CREAM, AUGMENTED / TOPICAL	10 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / RECTAL		90400 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
.ALPHA.-TOCOPHEROL	.ALPHA.-TOCOPHEROL	H4N855PNZ1	SOLUTION / ORAL	1.05 mg/1ml		Exact identifier — unii candidate 10 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	TABLET, EXTENDED RELEASE / ORAL	14 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	OINTMENT / RECTAL		27 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / OPHTHALMIC	1 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	LIQUID / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	LIQUID / RESPIRATORY (INHALATION)	10 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SPRAY, METERED / NASAL		240 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	LOTION / TOPICAL		3392 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / TOPICAL		7275 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	CREAM / TOPICAL		4213 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		19 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
LANOLIN	LANOLIN	7EV65EAW6H	CREAM / TOPICAL		10 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	CREAM / VAGINAL		40 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / INTRAVENOUS	5 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	SUPPOSITORY / RECTAL	375 mg		Exact identifier — unii candidate 6 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	FILM, SOLUBLE / BUCCAL		5 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL / VAGINAL		750 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	CAPSULE / VAGINAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL, FOAM / TOPICAL		72 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	CAPSULE, EXTENDED RELEASE / ORAL		71 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	SPONGE / TOPICAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION/ DROPS / OPHTHALMIC	0.75 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	63.4 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL / TOPICAL	1.05 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION, CONCENTRATE / ORAL		2590 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET, COATED / ORAL		16 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	TABLET, FILM COATED / ORAL	0.2 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	CAPSULE, DELAYED RELEASE / ORAL	1.7 mg		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / TOPICAL		4886 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	GEL / TOPICAL		14 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
LANOLIN	LANOLIN	7EV65EAW6H	LOTION / TOPICAL	1.5 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
LANOLIN	LANOLIN	7EV65EAW6H	OINTMENT / OPHTHALMIC	3 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	TABLET, EXTENDED RELEASE / ORAL	0.18 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
.ALPHA.-TOCOPHEROL	.ALPHA.-TOCOPHEROL	H4N855PNZ1	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 10 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SPONGE / TOPICAL	40 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	EMULSION / OPHTHALMIC	1.5 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL / RECTAL		3315 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
LANOLIN	LANOLIN	7EV65EAW6H	EMULSION / TOPICAL	0.25 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	INJECTION / INTRAMUSCULAR		7459 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / OPHTHALMIC	88.4 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	FILM / BUCCAL	1.48 mg		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	PASTE / DENTAL	0.5 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET, FILM COATED / ORAL		96 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL / TRANSDERMAL		500 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	JELLY / TOPICAL	20 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / VAGINAL		4084 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
LANOLIN	LANOLIN	7EV65EAW6H	CREAM / VAGINAL	2 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
.ALPHA.-TOCOPHEROL	.ALPHA.-TOCOPHEROL	H4N855PNZ1	TABLET, EXTENDED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	OINTMENT / TOPICAL		2100 mg	Exact identifier — unii candidate 15 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
2a846da9-2949-418e-b0c4-0eb2f0a58301			df95a616-714e-4727-af91-1b993a55b661	2020-01-16	Warnings, Adverse reactions	Exact identifier spl id: 2a846da9-2949-418e-b0c4-0eb2f0a58301 spl set id: df95a616-714e-4727-af91-1b993a55b661

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.